October 28, 2020
La participante explica por qué participa en el ensayo clínico de vacuna COVID-19
Janeth Pearl, residente de Cary, explica por qué participa en el ensayo clínico de la vacuna COVID-19.
Category: Infectious Diseases
October 21, 2020
Can Scientists take the STING out of Common Respiratory Viruses?
Led by Stan Lemon, MD, researchers at the UNC School of Medicine and GSK colleagues discovered that the majority of rhinoviruses need a human protein called STING to infect cells and replicate to cause disease.
October 15, 2020
Chapel Hill resident explains why she’s taking part in COVID-19 Vaccine Clinical Trial
Chapel Hill resident, Gracie Howell, explains why she's taking part in COVID-19 vaccine clinical trial held by UNC School of Medicine’s Infectious Diseases Division.
October 7, 2020
Cindy Gay Featured on NPR to Talk Vaccines
WUNC Producer Charlie Shelton-Ormond talks with Cindy Gay, MD, the primary investigator of a Phase 3 clinical trial for a COVID vaccine taking place at UNC-Chapel Hill.
September 17, 2020
Adimora Receives UNC’s Thomas Jefferson Award
Adaora Adimora, MD, PhD, professor of medicine in the division of infectious diseases and professor of epidemiology in the UNC Gillings School of Global Public Health, has been honored by her peers with the 2020 Thomas Jefferson Award.
August 27, 2020
Second Episode of ‘Confronting the HIV Epidemic’ Launched
The new video series from Medscape includes compelling stories of people living with HIV and interviews with UNC School of Medicine's Lisa Hightow-Weidman, MD, MPH, Kate Muessig, PhD, and Lina Rosengren-Hovee, MD, MPH, MS, of the UNC Behavior and Technology Lab in the division of infectious diseases.
August 20, 2020
Farel presents at 2020 National Ryan White Conference on HIV Care and Treatment
Claire Farel, MD, MPH, Medical Director of the UNC Infectious Disease Clinic, and Co-Director of the UNC Center for AIDS Research Clinical Core, gave a plenary talk at the 2020 National Ryan White Conference on HIV Care and Treatment.
August 10, 2020
How to Participate in a COVID-19 Vaccine Clinical Trial
A phase III clinical trial for the vaccine produced by Moderna is seeking 30,000 participants across the country.
July 8, 2020
UNC, EPA Researchers, Infection Prevention Experts Create Hierarchy of Mask Alternatives
With facemask donations pouring in and a proliferation of instructional videos for fabricating masks at home, UNC and EPA researchers are collaborating with infection prevention experts to test the performance of masks on campus, with the goal of providing UNC Health workers with the safest available masks at all times. The research collaboration is led by Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD.
May 26, 2020
Researchers Discover Key Player in Hepatitis A Virus Infection
The UNC School of Medicine lab of Stanley M. Lemon, MD, and colleagues used CRISPR-Cas9 gene editing to pinpoint a sugar-fatty acid molecule that acts like a gatekeeper to hepatitis A virus infection of human cells.
July 10, 2019
Commins appointed to national tick-borne disease working group
Scott Commins, MD, PhD, continues to research “alpha-gal” meat allergy and create awareness for the tick-borne illness as a new CDC research study begins. Recognized as a leading national expert, Commins will now guide a US DHHS Tick-Borne Working Group Subcommittee.
June 12, 2019
Ciccone Receives Thrasher Research Foundation Early Career Award
Emily Ciccone, MD, MHS, will use the $25,000 award to differentiate viral and bacterial respiratory infections among malaria-negative children. The overall goal is to reduce unnecessary antibiotic use without compromising safety in an area where access to care is a real issue.